Pages that link to "Q38502662"
Jump to navigation
Jump to search
The following pages link to Increased risk of death from primary hyperparathyroidism — an update (Q38502662):
Displaying 50 items.
- Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism (Q24685811) (← links)
- Unique clinical characteristics of primary hyperparathyroidism in India (Q28188640) (← links)
- Arterial structure and function in mild primary hyperparathyroidism is not directly related to parathyroid hormone, calcium, or vitamin D (Q28481344) (← links)
- A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia (Q28568245) (← links)
- Serum calcium level is related to both intima-media thickness and carotid atherosclerosis: a neglect risk factor in obese/overweight subjects (Q30532760) (← links)
- Subclinical and asymptomatic parathyroid disease: implications of emerging data (Q30776024) (← links)
- Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop (Q33569800) (← links)
- Primary hyperparathyroidism of postmenopausal women. Prospective population-based case-control analysis on prevalence, clinical findings and treatment. Minireview based on a doctoral thesis (Q33697089) (← links)
- Cardiac structure and diastolic function in mild primary hyperparathyroidism. (Q33849494) (← links)
- Interactions between adrenal-regulatory and calcium-regulatory hormones in human health (Q34008136) (← links)
- Role of surgery in mild primary hyperparathyroidism in the elderly (Q34106895) (← links)
- Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk? (Q34167589) (← links)
- Current status and treatment of primary hyperparathyroidism (Q34589346) (← links)
- Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). (Q34611536) (← links)
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. (Q34630666) (← links)
- The management of primary hyperparathyroidism (Q34769970) (← links)
- Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease (Q34985387) (← links)
- Parathyroid Surgery in the Elderly (Q35583883) (← links)
- Review of parathyroid surgery (Q35670735) (← links)
- Persistent and recurrent hyperparathyroidism (Q35826496) (← links)
- Primary hyperparathyroidism. Update on pathophysiology, clinical presentation and surgical treatment (Q36013618) (← links)
- Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results (Q36032077) (← links)
- Primary hyperparathyroidism, cognition, and health-related quality of life (Q36294817) (← links)
- New perspectives in the management of primary hyperparathyroidism (Q36327984) (← links)
- The diagnosis and management of asymptomatic primary hyperparathyroidism (Q36587575) (← links)
- Nontraditional manifestations of primary hyperparathyroidism. (Q36587833) (← links)
- Current pharmacological options for the management of primary hyperparathyroidism (Q36669632) (← links)
- Hyperparathyroidism: cancer and mortality (Q36701047) (← links)
- Cardiovascular aspects of primary hyperparathyroidism (Q37353636) (← links)
- The association between parathyroid hormone and mortality in dialysis patients is modified by wasting (Q37354867) (← links)
- Carotid vascular abnormalities in primary hyperparathyroidism (Q37379524) (← links)
- Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis (Q37457135) (← links)
- The Effect of Hyperparathyroid State on Platelet Functions and Bone Loss. (Q37548250) (← links)
- Should 'mild primary hyperparathyroidism' be reclassified as 'insidious': is it time to reconsider? (Q37919158) (← links)
- A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). (Q38441431) (← links)
- Identification of an RNA-binding protein that is phosphorylated by PTH and potentially mediates PTH-induced destabilization of Npt2a mRNA. (Q38797458) (← links)
- Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial (Q40073662) (← links)
- Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism (Q42166324) (← links)
- Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. (Q42915820) (← links)
- Insulin resistance before and after parathyroidectomy in patients with primary hyperparathyroidism--a pilot study (Q43090560) (← links)
- Urate and arteriosclerosis in primary hyperparathyroidism (Q43650572) (← links)
- Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism (Q43828840) (← links)
- Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years (Q43902765) (← links)
- Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism (Q44004873) (← links)
- Clinical outcome of diabetic peritoneal dialysis patients and evaluation of factors affecting mortality: a single centre's experience from Turkey (Q44223243) (← links)
- Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients (Q44342179) (← links)
- Death risk factor analysis in primary hyperparathyroidism (Q44516602) (← links)
- Arrhythmias in primary hyperparathyroidism evaluated by exercise test (Q44532609) (← links)
- Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism (Q46899630) (← links)
- Risk Factors for Intraoperative Hypertension during Surgery for Primary Hyperparathyroidism. (Q47308836) (← links)